Predictions
Fibrogen Inc.
Start price
Target price
Perf. (%)
€2.48
26.06.23
26.06.23
-
26.06.24
26.06.24
-1.61%
08.07.23
08.07.23
Probably not worthwhile Investment
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.22
22.05.22
22.05.22
-
22.05.23
22.05.23
-1.45%
22.05.23
22.05.23
Repligen Corp.
Start price
Target price
Perf. (%)
€264.10
27.11.21
27.11.21
€300.00
31.12.23
31.12.23
-46.31%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Bruker Corp.
Start price
Target price
Perf. (%)
€75.50
27.11.21
27.11.21
€100.00
31.12.23
31.12.23
-5.30%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Acceleron Pharma Inc.
Start price
Target price
Perf. (%)
€149.00
30.10.21
30.10.21
€180.00
31.12.23
31.12.23
6.71%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€45.00
03.01.23
03.01.23
€70.00
31.12.25
31.12.25
-10.09%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.78
13.01.23
13.01.23
€17.00
31.05.24
31.05.24
-9.18%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€74.46
07.09.22
07.09.22
€100.00
31.12.24
31.12.24
-29.49%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.65
03.01.23
03.01.23
€22.00
31.12.25
31.12.25
23.98%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Opko Health Inc.
Start price
Target price
Perf. (%)
€1.14
27.12.22
27.12.22
-
27.12.23
27.12.23
11.81%
24.04.23
24.04.23
Risky Investment
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€3.48
08.06.22
08.06.22
-
08.06.23
08.06.23
-14.83%
16.04.23
16.04.23
Risky Investment
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.86
12.04.22
12.04.22
-
12.04.23
12.04.23
-23.60%
12.04.23
12.04.23
Novocure Ltd
Start price
Target price
Perf. (%)
€64.20
16.03.22
16.03.22
€68.00
16.03.23
16.03.23
-6.99%
17.03.23
17.03.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Nektar Therapeutics
Start price
Target price
Perf. (%)
€2.02
23.01.23
23.01.23
-
23.01.24
23.01.24
-28.00%
03.03.23
03.03.23
Risky Investment
Novocure Ltd
Start price
Target price
Perf. (%)
€68.89
02.01.23
02.01.23
€30.00
31.12.25
31.12.25
71.43%
05.01.23
05.01.23
Could be very worthwhile Investment >20% year
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€136.00
28.12.21
28.12.21
€142.00
28.12.22
28.12.22
-70.42%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
Opko Health Inc.
Start price
Target price
Perf. (%)
€4.65
28.12.21
28.12.21
-
28.12.22
28.12.22
-75.54%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.99
27.12.21
27.12.21
€42.00
27.12.22
27.12.22
-5.05%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Neogen Corp.
Start price
Target price
Perf. (%)
€35.40
14.12.21
14.12.21
€38.00
14.12.22
14.12.22
-59.89%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.20
07.12.22
07.12.22
-
07.12.23
07.12.23
-16.53%
10.12.22
10.12.22
Risky Investment
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€76.50
21.08.22
21.08.22
€230.00
21.08.23
21.08.23
6.54%
04.09.22
04.09.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€214.90
21.08.22
21.08.22
€87.00
21.08.23
21.08.23
-3.44%
04.09.22
04.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group